Compounds > 1,2-distearoylphosphatidylethanolamine
Page last updated: 2024-08-26

1,2-distearoylphosphatidylethanolamine and amphotericin b

1,2-distearoylphosphatidylethanolamine has been researched along with amphotericin b in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iwatsuru, M; Maruyama, K; Moribe, K1
Maruyama, K; Moribe, K1
Hou, X; Li, S; Wang, X; Xie, J; Zhang, X1
Andes, D; Knilans, K; Kwon, GS; Vakil, R1
Jee, JP; McCoy, A; Mecozzi, S1

Reviews

1 review(s) available for 1,2-distearoylphosphatidylethanolamine and amphotericin b

ArticleYear
Pharmaceutical design of the liposomal antimicrobial agents for infectious disease.
    Current pharmaceutical design, 2002, Volume: 8, Issue:6

    Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Communicable Diseases; Drug Carriers; Drug Design; Liposomes; Lung; Nystatin; Phosphatidylethanolamines; Polyethylene Glycols; Solvents

2002

Other Studies

4 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and amphotericin b

ArticleYear
Molecular localization and state of amphotericin B in PEG liposomes.
    International journal of pharmaceutics, 1999, Dec-20, Volume: 193, Issue:1

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Amphotericin B; Cholesterol; Excipients; Fluorescence; Liposomes; Phosphatidylethanolamines; Polyethylene Glycols; Potassium; Solubility; Spectrum Analysis

1999
The study on brain targeting of the amphotericin B liposomes.
    Journal of drug targeting, 2003, Volume: 11, Issue:2

    Topics: Aminoglycosides; Amphotericin B; Animals; Anti-Bacterial Agents; Biological Transport; Blood-Brain Barrier; Bradykinin; Cell Membrane Permeability; Chromatography, High Pressure Liquid; In Vitro Techniques; Injections, Intravenous; Liposomes; Particle Size; Phosphatidylethanolamines; Polyethylene Glycols; Rats; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tissue Distribution

2003
Combination antifungal therapy involving amphotericin B, rapamycin and 5-fluorocytosine using PEG-phospholipid micelles.
    Pharmaceutical research, 2008, Volume: 25, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chemistry, Pharmaceutical; Drug Carriers; Drug Combinations; Drug Stability; Drug Synergism; Flucytosine; Micelles; Microbial Sensitivity Tests; Phosphatidylethanolamines; Polyethylene Glycols; Sirolimus; Solubility; Technology, Pharmaceutical

2008
Encapsulation and release of Amphotericin B from an ABC triblock fluorous copolymer.
    Pharmaceutical research, 2012, Volume: 29, Issue:1

    Topics: Amphotericin B; Anti-Bacterial Agents; Drug Carriers; Fluorescence Resonance Energy Transfer; Fluorocarbons; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Micelles; Molecular Structure; Phosphatidylethanolamines; Polyethylene Glycols; Serum; Surface Tension

2012